S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
66,000% upside on tiny biotech? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Laser breakthrough could send stock soaring 2,467% (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
66,000% upside on tiny biotech? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Laser breakthrough could send stock soaring 2,467% (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
66,000% upside on tiny biotech? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Laser breakthrough could send stock soaring 2,467% (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
66,000% upside on tiny biotech? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Laser breakthrough could send stock soaring 2,467% (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
NASDAQ:PEPG

PepGen (PEPG) Stock Forecast, Price & News

$12.28
-4.11 (-25.08%)
(As of 06/9/2023 ET)
Compare
Today's Range
$11.95
$16.39
50-Day Range
$9.27
$16.39
52-Week Range
$4.32
$20.00
Volume
213,035 shs
Average Volume
52,558 shs
Market Capitalization
$292.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.00

PepGen MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
119.9% Upside
$27.00 Price Target
Short Interest
Healthy
1.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.29mentions of PepGen in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$181,382 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($3.29) to ($3.34) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.99 out of 5 stars

Medical Sector

541st out of 987 stocks

Pharmaceutical Preparations Industry

254th out of 478 stocks


PEPG stock logo

About PepGen (NASDAQ:PEPG) Stock

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Receive PEPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PepGen and its competitors with MarketBeat's FREE daily newsletter.

PEPG Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
10-Q: PEPGEN INC.
PepGen: Q1 Earnings Insights
Short Interest in PepGen Inc. (NASDAQ:PEPG) Declines By 13.0%
H.C. Wainwright Keeps Their Buy Rating on PepGen Inc. (PEPG)
PepGen (NASDAQ:PEPG) Stock Rating Reaffirmed by HC Wainwright
PepGen (NASDAQ:PEPG) Earns "Buy" Rating from HC Wainwright
PepGen (NASDAQ:PEPG) Price Target Raised to $22.00 at Wedbush
PepGen Stock (NASDAQ:PEPG), Dividends
See More Headlines

PEPG Price History

PEPG Company Calendar

Last Earnings
5/11/2023
Today
6/09/2023
Next Earnings (Estimated)
8/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PEPG
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$27.00
High Stock Price Forecast
$33.00
Low Stock Price Forecast
$22.00
Forecasted Upside/Downside
+119.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-69,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$7.60 per share

Miscellaneous

Free Float
22,838,000
Market Cap
$292.02 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. James G. McArthur Ph.D. (Age 61)
    Pres, CEO, Treasurer, Sec. & Director
    Comp: $597.95k
  • Ms. Caroline Godfrey Ph.D.
    Founder & Scientific Advisory Board Member
  • Mr. Noel Donnelly M.B.A. (Age 53)
    Chief Financial Officer
    Comp: $519.65k
  • Dr. Jaya Goyal Ph.D. (Age 55)
    Exec. VP of Research & Preclinical Devel.
    Comp: $558.4k
  • Dr. Michael Gait
    Founder & Scientific Advisory Board Member
  • Dr. Sonia Bracegirdle DPHIL (Age 37)
    Sr. VP of Strategy & Operations
  • Ms. Jennifer Cormier
    Sr. VP of Clinical Operations
  • Dr. Michelle L. Mellion M.D. (Age 47)
    Sr. VP & Head of Clinical Devel.
  • Mr. Niels Svenstrup Ph.D. (Age 53)
    Sr. VP of Chemistry, Manufacturing & Control
  • Mr. Kyle Breidenstine
    VP of Fin. & Controller













PEPG Stock - Frequently Asked Questions

Should I buy or sell PepGen stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PepGen in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PEPG shares.
View PEPG analyst ratings
or view top-rated stocks.

What is PepGen's stock price forecast for 2023?

3 analysts have issued 1 year price objectives for PepGen's stock. Their PEPG share price forecasts range from $22.00 to $33.00. On average, they predict the company's share price to reach $27.00 in the next year. This suggests a possible upside of 119.9% from the stock's current price.
View analysts price targets for PEPG
or view top-rated stocks among Wall Street analysts.

How have PEPG shares performed in 2023?

PepGen's stock was trading at $13.37 at the start of the year. Since then, PEPG stock has decreased by 8.2% and is now trading at $12.28.
View the best growth stocks for 2023 here
.

When is PepGen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 11th 2023.
View our PEPG earnings forecast
.

How were PepGen's earnings last quarter?

PepGen Inc. (NASDAQ:PEPG) issued its quarterly earnings data on Thursday, May, 11th. The company reported ($0.69) EPS for the quarter, beating analysts' consensus estimates of ($0.79) by $0.10.

What ETFs hold PepGen's stock?

ETFs with the largest weight of PepGen (NASDAQ:PEPG) stock in their portfolio include Direxion mRNA ETF (MSGR) and iShares Neuroscience and Healthcare ETF (IBRN).iShares Biotechnology ETF (IBB).

When did PepGen IPO?

(PEPG) raised $126 million in an initial public offering (IPO) on Friday, May 6th 2022. The company issued 9,000,000 shares at a price of $13.00-$15.00 per share.

What is PepGen's stock symbol?

PepGen trades on the NASDAQ under the ticker symbol "PEPG."

Who are PepGen's major shareholders?

PepGen's stock is owned by many different retail and institutional investors. Top institutional shareholders include FMR LLC (10.98%), BlackRock Inc. (4.15%), Geode Capital Management LLC (1.02%), State Street Corp (0.87%), Bank of New York Mellon Corp (0.17%) and Charles Schwab Investment Management Inc. (0.16%). Insiders that own company stock include James G Mcarthur and Jaya Goyal.
View institutional ownership trends
.

How do I buy shares of PepGen?

Shares of PEPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PepGen's stock price today?

One share of PEPG stock can currently be purchased for approximately $12.28.

How much money does PepGen make?

PepGen (NASDAQ:PEPG) has a market capitalization of $292.02 million. The company earns $-69,100,000.00 in net income (profit) each year or ($3.67) on an earnings per share basis.

How can I contact PepGen?

The official website for the company is www.pepgen.com. The company can be reached via phone at 781-797-0979 or via email at investors@pepgen.com.

This page (NASDAQ:PEPG) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -